Jack Bevers Iii

7PUBLICATIONS

65CO-AUTHORS

AutoimmunityMolecular targetsTumour immunologyBiocatalysis and enzyme technologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jul 08, 2026

TREM1 signaling amplifies neutrophil-mediated inflammation in inflammatory bowel disease.

|Jan 07, 2026

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Feb 05, 2025

IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour control.

Béatrice Bréart, Katherine Williams, Stellanie Krimm

|Apr 25, 2024

AviTrap: A novel solution to achieve complete biotinylation.

Cheng Lu, Jack Bevers, Tulika Tyagi

|Jan 20, 2024

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists.

Matthew G Romei, Brandon Leonard, Zachary B Katz

|Jun 02, 2022

Antibody homotypic interactions are encoded by germline light chain complementarity determining region 2.

Brandon Leonard, Kannan Sankar, Matthew G Romei

Pageof 2

Frequent Collaborators

Nathaniel R West

Sarah E Headland

Reynold A Panettieri

Cynthia Koziol-White

Jason Vander Heiden

Riccardo Guidi

Daryle J DePianto

Katrina B Morshead

Alexander R Abbas

Jianyong Wang

Frequent Collaborators

Nathaniel R West

Sarah E Headland

Reynold A Panettieri

Cynthia Koziol-White